Mackenzie Financial’s Veradigm Inc. Common Stock MDRX Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2024
Q1
Sell
-45,211
Closed -$474K 1631
2023
Q4
$474K Sell
45,211
-15,039
-25% -$184K ﹤0.01% 1006
2023
Q3
$800K Buy
60,250
+15,318
+34% +$201K ﹤0.01% 899
2023
Q2
$568K Buy
44,932
+12,056
+37% +$146K ﹤0.01% 982
2023
Q1
$429K Buy
32,876
+5,700
+21% +$92.3K ﹤0.01% 1066
2022
Q4
$479K Sell
27,176
-3,530
-11% -$59.1K ﹤0.01% 941
2022
Q3
$468K Buy
+30,706
New +$497K ﹤0.01% 950
2022
Q2
Sell
-11,122
Closed -$250K 1570
2022
Q1
$250K Buy
+11,122
New +$225K ﹤0.01% 1202
2021
Q1
Sell
-32,320
Closed -$467K 1214
2020
Q4
$467K Sell
32,320
-70,030
-68% -$848K ﹤0.01% 851
2020
Q3
$833K Buy
+102,350
New +$836K ﹤0.01% 706
2020
Q1
Sell
-33,610
Closed -$330K 1192
2019
Q4
$330K Buy
+33,610
New +$354K ﹤0.01% 943

Other funds holding MDRX

Mackenzie Financial's MDRX Position: Q1 2024 in Review

Mackenzie Financial sold out of Veradigm Inc. Common Stock (MDRX) in Q1 2024, closing a stake of 45,211 shares — an estimated $474K sold.

Mackenzie Financial first reported a position in MDRX in Q4 2019 and held it in 10 quarters. The position peaked at $833K in Q3 2020. 35 funds tracked by Wall St. Rank hold MDRX as of Q1 2024.

  • Mackenzie Financial reported no remaining Veradigm Inc. Common Stock position as of Q1 2024 after selling out during the quarter.
  • Mackenzie Financial sold 45,211 Veradigm Inc. Common Stock shares in Q1 2024, an estimated $474K.
  • Mackenzie Financial first reported a position in Veradigm Inc. Common Stock in Q4 2019 and held it in 10 quarters.
  • Mackenzie Financial's Veradigm Inc. Common Stock position peaked at $833K in Q3 2020.
  • 35 funds tracked by Wall St. Rank held Veradigm Inc. Common Stock as of Q1 2024.

Based on Mackenzie Financial's 13F filing for Q1 2024, filed 10 May 2024.